Evidence map›Paper›PMID 28904129›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

T Cells Regulate Peripheral Naive Mature B Cell Survival by Cell-Cell Contact Mediated through SLAMF6 and SAP.

Lihi Radomir, Sivan Cohen, Matthias P Kramer, Eszter Bakos, Hadas Lewinsky, Avital Barak, Ziv Porat, Richard Bucala, Polina Stepensky, Shirly Becker-Herman and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Influence ofFrontiers in immunology · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Lihi RadomirDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Sivan CohenDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Matthias P KramerDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0002-0289-5261
Eszter BakosDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Hadas LewinskyDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Avital BarakDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Ziv PoratDepartment of Biological Services, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0003-3059-181X
Richard BucalaDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520; and.
Polina StepenskyPediatric Hematology-Oncology and Bone Marrow Transplantation Unit, Hadassah Hebrew University Medical Center, Jerusalem 91120, Israel.
Shirly Becker-HermanDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Idit ShacharDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel; idit.shachar@weizmann.ac.il.ORCID 0000-0003-0004-6159
American Committee for the Weizmann Institute of Science · USHadassah Medical Center · ILYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Rheumatic Diseases Research Core CenterP30AR053495 · NIAMS · YALE UNIVERSITY · PI SHLOMCHIK, WARREN D · 2007 to 2017
$7.0M
Mechanisms of Rheumatoid Synovial Fibroblast ActivationR01AR049610 · NIAMS · YALE UNIVERSITY · PI BUCALA, RICHARD J · 2002 to 2018
$5.0M
NCATS NIH HHS UL1 TR001863NIAMS NIH HHS P30 AR053495NIAMS NIH HHS R01 AR049610
6 · The paper itself

Abstract

The control of lymphoid homeostasis is the result of a very fine balance between lymphocyte production, proliferation, and apoptosis. In this study, we focused on the role of T cells in the maintenance/survival of the mature naive peripheral B cell population. We show that naive B and T cells interact via the signaling lymphocyte activation molecule (SLAM) family receptor, SLAMF6. This interaction induces cell type-specific signals in both cell types, mediated by the SLAM-associated protein (SAP) family of adaptors. This signaling results in an upregulation of the expression of the cytokine migration inhibitory factor in the T cells and augmented expression of its receptor CD74 on the B cell counterparts, consequently enhancing B cell survival. Furthermore, in X-linked lymphoproliferative disease patients, SAP deficiency reduces CD74 expression, resulting in the perturbation of B cell maintenance from the naive stage. Thus, naive T cells regulate B cell survival in a SLAMF6- and SAP-dependent manner.

Indexed as

AnimalsAntibodies, BlockingBlood CellsB-LymphocytesB-Lymphocyte SubsetsCell CommunicationCell DifferentiationCell ProliferationCells, CulturedCell SurvivalHomeostasisHumansLymphoproliferative DisordersMiceMice, Inbred C57BLMice, KnockoutAntibodies, BlockingRNA, Small InterferingSignaling Lymphocytic Activation Molecule Associated ProteinSignaling Lymphocytic Activation Molecule FamilySlamf6 protein, mouse

Identifiers

PMID28904129
PMCPMC5805483
OpenAlexW2754680191

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.